Baricitinib as an Effective Treatment for Lichen Planopilaris

The letter discusses the effectiveness of Baricitinib as a treatment for lichen planopilaris, a chronic inflammatory condition affecting hair follicles. The authors, affiliated with the Department of Dermatology at Peking University Shenzhen Hospital, present evidence supporting Baricitinib's potential in managing this condition. The study is backed by funding from the National Natural Science Foundation of China and other local medical projects. Although no abstract is available, the letter references several studies that highlight the clinical and molecular aspects of lichen planopilaris and previous treatments, suggesting that Baricitinib could be a promising therapeutic option.